Cure My Disease

Don't miss your cure!

 Log in / Sign up

Magnetic pulses may clear long COVID brain fog

NCT ID NCT06940609

Recruiting now Symptom relief Sponsor: University of New Mexico Source: ClinicalTrials.gov ↗

First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time

Summary

This trial tests whether a rapid, noninvasive magnetic brain stimulation called iTBS can reduce symptoms like brain fog, depression, and anxiety in people with Long COVID. Participants receive either real or sham stimulation and complete surveys, cognitive tests, and brain scans. The study also looks at whether the treatment lowers brain inflammation markers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
accelerated intermittent theta burst stimulation (iTBS), a noninvasive brain stimulation using magnetic fields
What this could lead to
If it works, this could point toward a non-drug treatment for Long COVID brain fog and related symptoms.
What could go wrong
This is a small, early-phase trial, so results may not apply to everyone. The treatment may not work better than a sham procedure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LONG COVID are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

long COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LONG COVID LONG COVID SYNDROME LONG COVID-19 SYNDROME PASC PASC POST ACUTE SEQUELAE OF COVID 19

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of New Mexico Health Science Center

    RECRUITING

    Albuquerque, New Mexico, 87106, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.